LDLR and Hypercholesterolemia: D374Y-PCSK9–transgenic pigs exhibited reduced hepatic LDL receptor levels, impaired LDL clearance, severe hypercholesterolemia, and spontaneous development of progressive atherosclerotic lesions that could be visualized by noninvasive imaging.